Alcohol and Cannabis Use Disorders Linked to Poorer Treatment Response in Adult ADHD, Small Study Finds
In revised parsimonious multivariable models, alcohol use disorder (OR≈0.08–0.10, p=0.010–0.026) and cannabis use disorder (OR≈0.20–0.24, p=0.014–0.028) were consistently associated with reduced odds of clinical response.
GLP-1 Receptor Agonist Response: Genetic Markers Explained
GLP-1 Clinical Relevance #40Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational StudyObesityGLP-1 Receptor AgonistEndocrinologyAdults with…
GLP-1 Receptor Agonist Response: What Genetics Reveals
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Genetic Pharmacology StudyGenome-Wide Association StudyGLP-1 Drug…
GLP-1 Receptor Agonist Response: How Genes Shape Outcomes
GLP-1 Clinical Relevance #43Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational StudyObesity TreatmentGLP-1 Receptor AgonistEndocrinologyAdults…
GLP-1 Receptor Agonist Response: Genetics & Side Effects
GLP-1 Clinical Relevance #46Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational StudyObesity TreatmentSemaglutideGLP-1 Receptor…
GLP-1 Receptor Agonist Evidence: Genetic Predictors
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic GLP-1 genetic predictorspharmacogenomics obesityweight loss responseGLP-1 side…